GIM-407
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GIM-407, covering 2025-07-10 to 2025-07-10. Get the full timeline:
Most recent: Clinical Trial Update: The Purpose of the Study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of GIM-407 [Phase 1]